Contact your GP if cold intolerance is severe, accompanied by fatigue, hair loss, bradycardia, or significantly impacts daily activities
Exendin-4 has been shown to reduce advanced glycation end product (AGE)-induced interleukin (IL)-6 and TNF- production, the expression of receptor for AGE (RAGE), and cell death in mesangial cells (Wang et al., 2014)
Onboarding and injection training lead demand because patients require clear guidance on device use, storage and dose-escalation routines when therapy begins.
Once weight stabilises, annual scans are usually sufficient
By trusting TrimRx, they avoid uncertainty and guesswork
Current options include participating in Phase 3 clinical trials at Canadian research sites (Vancouver, Toronto, Montreal, Calgary) or purchasing from research peptide suppliers for laboratory research purposes